Effect of AF, olaparib and aurola treatment on immune-related
Immunotherapeutic approaches for small-cell lung cancer
PDF) Auranofin Synergizes with the PARP Inhibitor Olaparib to
Evelien SMITS, Full Professor, PhD
Frontiers The potential of PARP inhibitors in targeted cancer therapy and immunotherapy
Inhibition of poly(ADP-ribosyl)ation in cancer: Old and new paradigms revisited - ScienceDirect
PDF) Auranofin Synergizes with the PARP Inhibitor Olaparib to
Effect of AF, olaparib and aurola treatment on immune-related
beta Actin Polyclonal Antibody (20536-1-AP)
Jinthe VAN LOENHOUT, PhD Student
Interface between obesity with dysfunctional metabolism and inflammation, and the triple-negative breast cancer in African American women
The intracellular gold concentration levels caused by the
Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review - ScienceDirect
Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer
Lived experiences of women reporting fatigue during PARP inhibitor maintenance treatment for advanced ovarian cancer: A qualitative study - Gynecologic Oncology